Lonza Group Ag Pre-Paid Expenses 2012-2024 | LZAGY

Lonza Group Ag pre-paid expenses from 2012 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Lonza Group Ag pre-paid expenses for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Lonza Group Ag pre-paid expenses for 2023 were $0B, a 0% decline from 2022.
  • Lonza Group Ag pre-paid expenses for 2022 were $0B, a 0% decline from 2021.
  • Lonza Group Ag pre-paid expenses for 2021 were $0B, a 0% decline from 2020.
Lonza Group Ag Annual Pre-Paid Expenses
(Millions of US $)
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
Lonza Group Ag Quarterly Pre-Paid Expenses
(Millions of US $)
2024-12-31
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.244B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.034B 28.02
Boston Scientific (BSX) United States $152.131B 38.08
Stryker (SYK) United States $146.225B 30.58
EssilorLuxottica (ESLOY) France $128.281B 0.00
Medtronic (MDT) Ireland $111.581B 15.82
Haleon (HLN) United Kingdom $50.069B 28.51
ResMed (RMD) United States $36.611B 27.50
GE HealthCare Technologies (GEHC) United States $32.762B 15.55
Agilent Technologies (A) United States $32.366B 21.10
Terumo (TRUMY) Japan $26.576B 34.52
Insulet (PODD) United States $22.320B 87.61
Koninklijke Philips (PHG) Netherlands $21.929B 15.76
Zimmer Biomet Holdings (ZBH) United States $18.186B 11.68
Baxter (BAX) United States $15.472B 11.55
Smith & Nephew SNATS (SNN) United Kingdom $13.270B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.449B 0.00
Bio-Rad Laboratories (BIO) United States $5.968B 20.77
Lantheus Holdings (LNTH) United States $5.558B 14.02
Prestige Consumer Healthcare (PBH) United States $4.181B 18.68
Perrigo (PRGO) Ireland $3.570B 9.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.382B 15.40
ICU Medical (ICUI) United States $3.271B 24.12
Envista Holdings (NVST) United States $3.166B 26.31
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.022B 13.91
LeMaitre Vascular (LMAT) United States $1.884B 42.12
AtriCure (ATRC) United States $1.726B 0.00
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.080B 24.29
Neogen (NEOG) United States $1.066B 13.64
Kestra Medical Technologies (KMTS) United States $1.025B 0.00
BioLife Solutions (BLFS) United States $1.021B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.38
InMode (INMD) Israel $0.906B 9.13
CeriBell (CBLL) United States $0.633B 0.00
Evolus (EOLS) United States $0.628B 0.00
Capricor Therapeutics (CAPR) United States $0.602B 0.00
Owens & Minor (OMI) United States $0.588B 4.88
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.553B 0.00
Valneva SE (VALN) France $0.525B 0.00
Surmodics (SRDX) United States $0.426B 0.00
Tilray Brands (TLRY) Canada $0.391B 0.00
VAREX IMAGING (VREX) United States $0.345B 12.68
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.304B 54.10
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.264B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.97
Cresco Labs (CRLBF) United States $0.260B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.254B 11.54
Canopy Growth (CGC) Canada $0.252B 0.00
Sanuwave Health (SNWV) United States $0.238B 0.00
OraSure Technologies (OSUR) United States $0.210B 0.00
TriSalus Life Sciences (TLSI) United States $0.202B 0.00
Biote (BTMD) United States $0.201B 5.65
Quanterix (QTRX) United States $0.200B 0.00
Brainsway (BWAY) Israel $0.195B 51.55
Omeros (OMER) United States $0.193B 0.00
Verano Holdings (VRNOF) United States $0.191B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
Organigram Global (OGI) Canada $0.175B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.127B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
MacroGenics (MGNX) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.60
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
Agape ATP (ATPC) $0.073B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.036B 48.57
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00